Erratum: Urine analysis of glucose tetrasaccharide by HPLC; a useful marker for the investigation of patients with Pompe and other glycogen storage diseases (Journal of Inherited Metabolic Disease DOI:10.1007/s10545-011-9360-2);Urine analysis of glucose tetrasaccharide by HPLC; A useful marker for the investigation of patients with Pompe and other glycogen storage diseases

Journal of Inherited Metabolic Disease

Volumn 35, Issue 2, 2012, Pages 311-316

  Manwaring, Victoria ^a,b   Prunty, Helen ^a   Bainbridge, Katie ^a   Burke, Derek ^a,b   Finnegan, Niamh ^a   Franses, Rebecca ^a   Lam, Amanda ^a   Vellodi, Ashok ^a   Heales, Simon ^a,b  

^a GREAT ORMOND STREET HOSPITAL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREATININE; GLUCAN 1,4 ALPHA GLUCOSIDASE; GLUCOSE TETRASACCHARIDE; TETRASACCHARIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CHILD; CLINICAL ARTICLE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CREATININE URINE LEVEL; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFERENTIAL DIAGNOSIS; ELECTROCHEMICAL DETECTION; ENZYME ACTIVITY; ENZYME ANALYSIS; ENZYME REPLACEMENT; FEMALE; GLUCOSE URINE LEVEL; GLYCOGEN STORAGE DISEASE TYPE 1; GLYCOGEN STORAGE DISEASE TYPE 1A; GLYCOGEN STORAGE DISEASE TYPE 2; GLYCOGEN STORAGE DISEASE TYPE 3; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; INFANT; LIMIT OF DETECTION; MALE; PRESCHOOL CHILD; SCHOOL CHILD; URINALYSIS;

EID: 84863444457     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-011-9383-8     Document Type: Erratum

References (18)

1. An Y, Young SP, Hillman SL, Van Hove JLK, Chen Y-T et al (2000) Liquid chromatographic assay for a glucose tetrasaccharide, a putative biomarker for the diagnosis of Pompe disease. Anal Biochem 287(1):136-143
2. An Y, Young SP, Kishnani PS, Millington DS, Amalfitano A, Corzo D, Chen Y-T (2005) Glucose tetrasaccharide as a biomarker for monitoring the therapeutic response to enzyme replacement therapy for Pompe disease. Mol Genet Metab 85(4):247-254
3. Ausems M et al. (1999) Frequency of glycogen storage disease type II in the Netherlands: implications for diagnosis and genetic counselling. Eur J Hum Genet 7:713-716
4. Baldwin RP (1999) Electrochemical determination ofcarbohydrates: enzyme electrodes and amperometric detection in liquid chroma- tography and capillary electrophoresis. J Pharm Biomed Anal 19 (1-2):69-81
5. Chamoles NA et al (2004) Glycogen storage disease type II: enzymatic screening in dried blood spots on filter paper. Clin Chim Acta 347(1-2):97-102
6. Diggelen OP et al (2009) Enzyme analysis for Pompe disease in leukocytes; superior results with natural substrate compared with artificial substrates. J Inherit Metab Dis 32(3):416-423
7. Dionex (2000) Technical note 20: analysis of carbohydrates by high performance anion exchange chromatography with pulsed am- perometric detection (HPAE-PAD). http://www.dionex.com/en-us/ webdocs/5023-TN20.pdf Accessed May 2011
8. Ersser RS (1979) The identity and origin ofoligosaccharides present in the faeces and urine of sick infants. Clin Chim Acta 97(2- 3):225-237
9. Kishnani PS, Hwu W-L, Mandel H, Nicolino M, Yong F et al (2006) A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr 148(5):671- 676, e2
10. Lennartson G et al (1976) Quantitation of a urinary tetrasaccharide by gas chromatography and mass spectrometry. Biol Mass Spectrom 3(2):51-54
11. Martiniuk F, Chen A, Mack A, Arvanitopoulos E, Chen Y et al (1998) Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. Am J Med Genet 79(1):69-72
12. Schoser B, Hill V, Raben N (2008) Therapeutic approaches in glycogen storage disease type II/Pompe sisease. Neurotherapeutics 5(4):569-578
13. Scriver CR et al. (2000) The metabolic and molecular bases of inherited disease, 8th ed. McGraw-Hill, New York
14. Van den Hout JMP et al (2004) Long-term intravenous treatment of Pompe disease with recombinant human {alpha}-glucosidase frommilk. Pediatrics 113(5):e448-e457
15. Winchester B et al (2008) Methods for a prompt and reliable laboratory diagnosis of Pompe disease: report from an international consensus meeting. Mol Genet Metab 93 (3):275-281
16. Winkel LPF et al (2005) The natural course of non-classic Pompe's disease; a review of 225 published cases. J Neurol 252(8):875-884
17. Young SP, Stevens RD, An Y, Chen Y-T, Millington DS (2003) Analysis of a glucose tetrasaccharide elevated in Pompe disease by stable isotope dilution-electrospray ionization tandem mass spectrometry. Anal Biochem 316(2):175-180
18. Young SP, Zhang H, Corzo D, Thurberg BL, Bali D et al (2009) Long-term monitoring of patients with infantile-onset Pompe disease on enzyme replacement therapy using a urinary glucose tetrasaccharide biomarker. Genet Med 11(7):536-541